2011
DOI: 10.1016/j.jpain.2011.02.247
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes associated with tampering of EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release Capsules: a review of the first 12 months of postmarketing adverse event data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance